Related Experiment Video
Updated: Apr 26, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long non-coding RNAs in cancer: implications for personalized therapy
Marianna Vitiello1, Andrea Tuccoli, Laura Poliseno
1Oncogenomics Unit, Core Research Laboratory, Istituto Toscano Tumori c/o IFC-CNR, via Moruzzi 1, 56124, Pisa, Italy.
Long non-coding RNAs (lncRNAs), including pseudogenes and circular RNAs (circRNAs), are key in cancer development and personalized medicine. These molecules show promise as diagnostic biomarkers and therapeutic targets, though clinical application faces challenges.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs), pseudogenes, and circular RNAs (circRNAs) are emerging as significant factors in cancer biology.
- Their roles in cancer pathogenesis are increasingly recognized, highlighting their potential impact on personalized cancer medicine.
Purpose of the Study:
- To review the roles of lncRNAs, pseudogenes, and circRNAs in cancer.
- To discuss their utility as diagnostic and prognostic biomarkers.
- To explore their potential as therapeutic targets and drugs in clinical practice.
Main Methods:
- Literature review of recent studies on lncRNAs, pseudogenes, and circRNAs in cancer.
- Analysis of their applications in diagnostics, prognostics, and therapeutics.
- Discussion of current limitations for clinical translation.
Main Results:
- lncRNAs, pseudogenes, and circRNAs are implicated in various aspects of cancer development and progression.
- These non-coding RNAs demonstrate potential as reliable biomarkers for cancer diagnosis and prognosis.
- They also present opportunities for targeted cancer therapies and drug development.
Conclusions:
- lncRNAs, pseudogenes, and circRNAs hold significant promise for advancing personalized cancer medicine.
- Further research and development are needed to overcome existing limitations for their widespread clinical adoption.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
MicroRNAs
